BioSpace News Archive

Biotech Beach

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - June 06, 2023

Puma Biotechnology, Inc., a biopharmaceutical company, announced that on June 2, 2023, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering 22,500 shares of Puma common stock to three new non-executive employees.

June 6, 2023
·
2 min read
Connecta Therapeutics starts clinical trials for its Fragile X syndrome drug

This Phase I clinical trial will assess the safety and tolerability of CTH120, which acts as a neuroplasticity modulator.

June 6, 2023
·
3 min read
Genetown

LeMaitre to Present at Upcoming Investor Conferences in June 2023

LeMaitre Vascular, Inc. announced that it is participating in two upcoming investor conferences in June.

June 6, 2023
·
1 min read
ExThera Medical Exhibits at the 2023 International Conference on Extracorporeal Organ Support in Zagreb, Croatia

ExThera Medical, a healthcare company that has developed and commercialized a unique extracorporeal blood filtration medical device, participated in the annual International Conference on Extracorporeal Organ Support.

June 6, 2023
·
4 min read
BioMidwest

Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock

Cogent Biosciences, Inc., a biotechnology company focused on developing precision therapies for genetically defined diseases, announced the pricing of its previously announced underwritten public offering of 12,500,000 shares of its common stock, offered at a public offering price of $12.00 per share.

June 6, 2023
·
5 min read
Business

Nona Biosciences Appoints Steve Arkinstall, D. Phil., as Chief Scientific Advisor

Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited, committed to cutting-edge antibody technology innovation and provider of integrated solutions from “Idea to IND” (I to I™), today announced the appointment of Steve Arkinstall, D.Phil., as its Chief Scientific Advisor.

June 6, 2023
·
2 min read
BioForest

OnQuality Announces FDA Clearance of IND Application for OQL051, for the Prophylaxis of Chemotherapy-Induced Diarrhea

OnQuality Pharmaceuticals (“OnQuality”), announced today the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for its drug candidate, OQL051.

June 6, 2023
·
5 min read
Biotech Bay

Day One Announces Pricing of Public Offering of Common Stock - June 07, 2023

Day One Biopharmaceuticals, Inc. announced the pricing of its underwritten public offering of 11,538,462 shares of its common stock at a public offering price of $13.00 per share.

June 6, 2023
·
4 min read
Lone Star Bio

Lexicon Pharmaceuticals to Participate in the Jefferies 2023 Global Healthcare Conference

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the Jefferies 2023 Global Healthcare Conference, taking place June 7-9, 2023.

June 6, 2023
·
3 min read
Kiniksa Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference

Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that management will participate in a fireside chat at the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13, 2023 at 8:40 a.m. Pacific Time (11:40 a.m. Eastern Time).

June 6, 2023
·
1 min read